Cargando…

Meta-analysis of risk factors for Parkinson’s disease dementia

BACKGROUND: Parkinson’s disease (PD) is a common heterogeneous neurodegenerative disorder in elder population. Parkinson’s disease dementia (PDD) is one of the most common non-motor manifestations in PD patients. No comprehensive review has been conducted to assess risk factors for PDD. METHODS: A s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yaqian, Yang, Jing, Shang, Huifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890279/ https://www.ncbi.nlm.nih.gov/pubmed/27257478 http://dx.doi.org/10.1186/s40035-016-0058-0

Ejemplares similares

Genetic heterogeneity on sleep disorders in Parkinson’s disease: a systematic review and meta-analysis
por: Huang, Jingxuan, et al.
Publicado: (2022)

Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
por: Zou, Jing, et al.
Publicado: (2018)

Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Jiang, Zheng, et al.
Publicado: (2020)

Meta-Analysis of the Relationship between the APOE Gene and the Onset of Parkinson's Disease Dementia
por: Pang, Suisui, et al.
Publicado: (2018)

Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis
por: Xu, Lizhen, et al.
Publicado: (2020)

Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Cai, Yingying, et al.
Publicado: (2021)

Risk of dementia or Parkinson’s disease in the presence of Sjögren’s syndrome: A systematic review and meta-analysis
por: Wang, Zhen-Zhi, et al.
Publicado: (2022)

The Impact of Motor-Cognitive Dual-Task Training on Physical and Cognitive Functions in Parkinson’s Disease
por: Xiao, Yi, et al.
Publicado: (2023)

Association between the risk and severity of Parkinson’s disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis
por: Quan, Yuxin, et al.
Publicado: (2023)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
por: Meng, Yan-Hong, et al.
Publicado: (2019)

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease
por: Chan, Po‐Chi, et al.
Publicado: (2018)

Diagnosis and management of Parkinson's disease dementia
por: Poewe, W, et al.
Publicado: (2008)

Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review
por: Kong, Linghui, et al.
Publicado: (2022)

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
por: Bittner, Nadine, et al.
Publicado: (2023)

Association Between Serum Vitamin D Levels and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Luo, Xiaoyue, et al.
Publicado: (2018)

Dementia-Free Survival and Risk Factors for Dementia in a Hospital-Based Korean Parkinson's Disease Cohort
por: Lee, Su-Yun, et al.
Publicado: (2017)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies
por: Weil, Rimona S., et al.
Publicado: (2017)

Rheumatoid arthritis decreases risk for Parkinson’s disease: a Mendelian randomization study
por: Li, ChunYu, et al.
Publicado: (2021)

Can neuroimaging predict dementia in Parkinson’s disease?
por: Lanskey, Juliette H, et al.
Publicado: (2018)

Risk factors associated with post-stroke dementia: a systematic review and meta-analysis
por: Surawan, Jesada, et al.
Publicado: (2017)

Schizophrenia and risk of dementia: a meta-analysis study
por: Cai, Laisheng, et al.
Publicado: (2018)

Phenomenology and management of cognitive and behavioral disorders in Parkinson's disease. Rise and logic of dementia in Parkinson's disease
por: Potagas, Constantin, et al.
Publicado: (2006)

Dementia Risk Prediction in a Longitudinal Geriatric Parkinson’s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale
por: Bohn, Linzy, et al.
Publicado: (2023)

Visual tests predict dementia risk in Parkinson disease
por: Leyland, Louise-Ann, et al.
Publicado: (2020)

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
por: Noyce, Alastair J, et al.
Publicado: (2012)

Heart disease as a risk factor for dementia
por: Justin, B Ng, et al.
Publicado: (2013)

Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis
por: Zhao, Yujia, et al.
Publicado: (2023)

Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
por: Chang, Hongtao, et al.
Publicado: (2022)

QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study
por: Liu, Hailing, et al.
Publicado: (2022)

Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
por: Walker, Zuzana, et al.
Publicado: (2018)

Antisaccades in Parkinson’s Disease: A Meta-Analysis
por: Waldthaler, Josefine, et al.
Publicado: (2021)

Parkinson’s disease dementia: a neural networks perspective
por: Gratwicke, James, et al.
Publicado: (2015)

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
por: Jellinger, Kurt A., et al.
Publicado: (2018)

Risk of Nonmelanoma Skin Cancers and Parkinson’s Disease—Meta-Analysis and Systematic Review
por: Krasowska, Danuta, et al.
Publicado: (2021)

Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View
por: Hou, Yanbing, et al.
Publicado: (2022)

Diabetes and Risk of Parkinson’s Disease: A systematic review and meta-analysis
por: Cereda, Emanuele, et al.
Publicado: (2011)

Serum inflammatory cytokines levels and the correlation analyses in Parkinson’s disease
por: Fu, Jiajia, et al.
Publicado: (2023)

Meta-Analysis: Overweight, Obesity, and Parkinson's Disease
por: Chen, Jinhu, et al.
Publicado: (2014)

Evidence for Peripheral Immune Activation in Parkinson’s Disease
por: Chen, Xueping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_302tur5vstcatmbbb8dlc23761